Table 4.
Prevalence of microalbuminuria in participants with hypertension or DM according to age groups and level of renal function.
| ACR (30–300 mg/g)* | ||||
|---|---|---|---|---|
| Age (years) | 18–39 | 40–59 | ≥60 | All ages |
| Hypertension | ||||
| eGFR (mL/min/1.73 m2) | ||||
| <60 | 1 (1.1) | 4 (4.3) | 7 (7.4) | 12 (12.8) |
| ≥60 | 8 (0.9) | 25 (2.9) | 20 (2.3) | 53 (6.2) |
| Diabetes | ||||
| eGFR (mL/min/1.73 m2) | ||||
| <60 | 0 (0.0) | 3 (3.2) | 4 (4.3) | 7 (7.4) |
| ≥60 | 8 (0.9) | 14 (1.6) | 17 (2.0) | 39 (4.6) |
| Diabetes + hypertension | ||||
| eGFR (mL/min/1.73 m2) | ||||
| <60 | 0 (0.0) | 3 (3.3) | 4 (4.3) | 7 (7.6) |
| ≥60 | 2 (0.2) | 12 (1.4) | 15 (1.7) | 29 (3.3) |
Data are a number of screened subjects and percent (%) if not otherwise specified. ACR: urinary albumin/creatinine ratio. eGFR: estimated glomerular filtration rate. Microalbuminuria: ACR 30–300 mg/dL. *Hypertension is defined as participants with SBP >140 mm Hg or DBP >90 mm Hg, or receiving treatment for previously diagnosed hypertension. °Diabetes is defined as participants reporting a history of, or currently treated for diabetes mellitus, or with fasting blood glucose level ≥126 mg/dL.